US Stock MarketDetailed Quotes

ALNY Alnylam Pharmaceuticals

Watchlist
  • 245.440
  • +6.570+2.75%
Close Dec 20 16:00 ET
  • 245.440
  • 0.0000.00%
Post 16:59 ET
31.66BMarket Cap-93.68P/E (TTM)

Alnylam Pharmaceuticals Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Dec 20, 2024

Based on 21 analysts giving stock ratings to Alnylam Pharmaceuticals in the past 3 months

Buy

  • Buy

    76.19%
  • Hold

    19.05%
  • Sell

    4.76%

Price Target

Updated: Dec 20, 2024

The average Alnylam Pharmaceuticals stock price target is 315.26 with a max estimate of 400.00 and a min estimate of 205.00

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 20, 2024

Buy

  • Buy

    76.19%
  • Hold

    19.05%
  • Sell

    4.76%

Price Target

Updated: Dec 20, 2024